person

Pedro M.

Country
Portugal
Department
Psychiatry

Research Overview

Data & Insights

medical_services
Primary Speciality
Main therapeutic area

handshake
Return Partnerships
Recurring site collaborations
1
Sites with multiple studies

Has run more than one trial at 1 of 34 partner sites.

Specializations

Psychiatric Disorders

The investigator specializes in treating complex psychiatric conditions, with particular emphasis on obsessive-compulsive disorder (OCD) and schizophrenia. Their research focuses on developing innovative therapeutic approaches for treatment-resistant cases.

  • Treatment-Resistant OCD Management
  • Antipsychotic Therapy Optimization
  • Pharmacological Intervention Strategies

Their work explores novel therapeutic options for patients who have not responded adequately to conventional treatments.

Therapeutic Innovation

The investigator's expertise extends to evaluating new therapeutic compounds and treatment approaches in neuropsychiatric disorders. Their research encompasses comparative medication studies and bioavailability assessments.

  • Novel Drug Applications
  • Treatment Enhancement Strategies
  • Medication Response Assessment

Their work contributes to advancing treatment options in psychiatric care through systematic evaluation of therapeutic alternatives.

Clinical Pharmacology

The investigator focuses on understanding pharmacokinetic profiles of psychiatric medications and their clinical applications. Their research includes evaluation of different dosing strategies and medication comparisons.

  • Pharmacokinetic Analysis
  • Dose Optimization Studies
  • Comparative Medication Research

Their expertise encompasses the assessment of medication efficacy and biological response in psychiatric conditions.

Related Investigators

Researchers in similar fields or departments

Want to know more about this investigator?

We can share extended profile information and contact details.

Is something out of date?

Tell us what needs correcting and we'll update this profile.